Applications Claiming Priority (5) Publications (2) Family ID=26809911 Family Applications (1) Country Status (18) Cited By (1) Families Citing this family (12) Family Cites Families (14) 1999 1999-12-10 TW TW088121700A patent/TWI230618B/en not_active IP Right Cessation 1999-12-13 CO CO99077816A patent/CO5261557A1/en active IP Right Grant 1999-12-14 EP EP99967310A patent/EP1140114B1/en not_active Expired - Lifetime 1999-12-14 NZ NZ511855A patent/NZ511855A/en not_active IP Right Cessation 1999-12-14 MY MYPI99005427A patent/MY126526A/en unknown 1999-12-14 KR KR1020017007531A patent/KR100624214B1/en not_active Expired - Lifetime 1999-12-14 TR TR2001/01746T patent/TR200101746T2/en unknown 1999-12-14 CA CA002355239A patent/CA2355239C/en not_active Expired - Lifetime 1999-12-14 AU AU23613/00A patent/AU759869B2/en not_active Expired 1999-12-14 CN CNB2005100659791A patent/CN100361664C/en not_active Expired - Lifetime 1999-12-14 ES ES99967310T patent/ES2245130T3/en not_active Expired - Lifetime 1999-12-14 CN CNB998145289A patent/CN1202829C/en not_active Expired - Lifetime 1999-12-14 AT AT99967310T patent/ATE298576T1/en not_active IP Right Cessation 1999-12-14 AR ARP990106372A patent/AR021670A1/en active IP Right Grant 1999-12-14 DE DE69926012T patent/DE69926012T2/en not_active Expired - Lifetime 1999-12-14 BR BRPI9916820A patent/BRPI9916820B8/en not_active IP Right Cessation 1999-12-14 JP JP2000587780A patent/JP4750946B2/en not_active Expired - Lifetime 1999-12-14 ID IDW00200101527A patent/ID30032A/en unknown 1999-12-14 WO PCT/US1999/029626 patent/WO2000035460A2/en not_active Ceased
This proposal would allow Americans and their doctors to determine the best path forward so they can lead healthier lives, without worrying about their ability to cover these drugs out-of-pocket, and ultimately reduce health care costs to our nation," the statement added
Sever M, Klicek R, Radic B, et al
FAQ Section: At Facelit Clinic, youll have a quick consultation with a healthcare professional who will assess your lifestyle, health goals, and nutrient needs before recommending the right drip
The lack of commonly available antibodies to detect GIPR is another limitation that hampers immunohistochemical analysis of potentially relevant drug targets in the brain
